Stockreport

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)* [Yahoo! Finance]

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time
PDF with a novel mechanism of action in more than 20 years for the maintenance treatment of COPD. COLUMBIA, S.C. Sept. 17, 2024 /PRNewswire/ -- The Ritedose Corporation In [Read more]